These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 34170848)
1. Computational study on new natural compound agonists of dopamine receptor. Li H; Yang W; Xi J; Wang Z; Lu H; Du Z; Li W; Wu B; Jiang S; Peng Y; Liu J; Liu L; Zhang X; Feng J Aging (Albany NY); 2021 Jun; 13(12):16620-16636. PubMed ID: 34170848 [TBL] [Abstract][Full Text] [Related]
2. Computational Study and Modified Design of Selective Dopamine D3 Receptor Agonists. Duan X; Zhang X; Xu B; Wang F; Lei M Chem Biol Drug Des; 2016 Jul; 88(1):142-54. PubMed ID: 26851125 [TBL] [Abstract][Full Text] [Related]
3. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors. Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114 [TBL] [Abstract][Full Text] [Related]
4. Design of novel dopamine D Zhang C; Li Q; Meng L; Ren Y J Biomol Struct Dyn; 2020 Feb; 38(3):860-885. PubMed ID: 30916624 [TBL] [Abstract][Full Text] [Related]
5. CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors. Wilcox RE; Huang WH; Brusniak MY; Wilcox DM; Pearlman RS; Teeter MM; DuRand CJ; Wiens BL; Neve KA J Med Chem; 2000 Aug; 43(16):3005-19. PubMed ID: 10956209 [TBL] [Abstract][Full Text] [Related]
6. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations. Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912 [TBL] [Abstract][Full Text] [Related]
7. Computational study on new natural compound agonists of stimulator of interferon genes (STING). Zhong S; Li W; Bai Y; Wu B; Wang X; Jiang S; Zhao Y; Ren J; Li H; Jin R PLoS One; 2019; 14(5):e0216678. PubMed ID: 31120925 [TBL] [Abstract][Full Text] [Related]
8. Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7. Gupta CL; Babu Khan M; Ampasala DR; Akhtar S; Dwivedi UN; Bajpai P J Biomol Struct Dyn; 2019 Nov; 37(18):4721-4736. PubMed ID: 30661449 [TBL] [Abstract][Full Text] [Related]
9. Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1. Jiang S; Li H; Piao L; Jin Z; Liu J; Chen S; Liu LL; Shao Y; Zhong S; Wu B; Li W; Ren J; Zhang Y; Wang H; Jin R Aging (Albany NY); 2020 Jun; 12(12):11349-11363. PubMed ID: 32568737 [TBL] [Abstract][Full Text] [Related]
10. Absence of D2S dopamine receptor in the prolactin-secreting MMQ pituitary clone: characterization of a wild D2L receptor coupled to native transduction mechanisms. Ventra C; Meucci O; Grimaldi M; Scorziello A; Porcellini A; Schettini G J Mol Endocrinol; 1995 Jun; 14(3):375-89. PubMed ID: 7669227 [TBL] [Abstract][Full Text] [Related]
11. Computational study of effective matrix metalloproteinase 9 (MMP9) targeting natural inhibitors. Liu N; Wang X; Wu H; Lv X; Xie H; Guo Z; Wang J; Dou G; Zhang C; Sun M Aging (Albany NY); 2021 Oct; 13(19):22867-22882. PubMed ID: 34607974 [TBL] [Abstract][Full Text] [Related]
12. Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis. Kumar A; Roy S; Tripathi S; Sharma A J Biomol Struct Dyn; 2016; 34(2):239-49. PubMed ID: 25707809 [TBL] [Abstract][Full Text] [Related]
13. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach. Ambure P; Bhat J; Puzyn T; Roy K J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387 [TBL] [Abstract][Full Text] [Related]
14. Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, ADMET, and Molecular Dynamics (MD) Simulation of Potential Inhibitors of PD-L1 from the Library of Marine Natural Products. Luo L; Zhong A; Wang Q; Zheng T Mar Drugs; 2021 Dec; 20(1):. PubMed ID: 35049884 [TBL] [Abstract][Full Text] [Related]
15. Tumor stem-like cells isolated from MMQ cells resist to dopamine agonist treatment. Cai L; Chen J; Lu J; Li Q; Chen X; Zhang L; Wu J; Zheng W; Wang C; Su Z Mol Cell Endocrinol; 2021 Sep; 535():111396. PubMed ID: 34271069 [TBL] [Abstract][Full Text] [Related]
16. Identification of potential dual agonists of FXR and TGR5 using e-pharmacophore based virtual screening. Sindhu T; Srinivasan P Mol Biosyst; 2015 May; 11(5):1305-18. PubMed ID: 25787676 [TBL] [Abstract][Full Text] [Related]
17. Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists. Pandey P; Roy KK; Liu H; Ma G; Pettaway S; Alsharif WF; Gadepalli RS; Rimoldi JM; McCurdy CR; Cutler SJ; Doerksen RJ Molecules; 2018 Oct; 23(10):. PubMed ID: 30322136 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a novel class of atypical dopamine receptor agonists. Kuzhikandathil EV; Kortagere S Pharm Res; 2012 Aug; 29(8):2264-75. PubMed ID: 22547031 [TBL] [Abstract][Full Text] [Related]
19. Structural Investigation of the Dopamine-2 Receptor Agonist Bromocriptine Binding to Dimeric D2 Salmas RE; Seeman P; Stein M; Durdagi S J Chem Inf Model; 2018 Apr; 58(4):826-836. PubMed ID: 29537837 [TBL] [Abstract][Full Text] [Related]
20. Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV. Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N J Biomol Struct Dyn; 2019 Jan; 37(1):131-146. PubMed ID: 29268664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]